Llwytho...
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
OBJECTIVE: Immune complexes (ICs) play a critical role in the pathology of autoimmune diseases. The aim of this study was to generate and characterise a first-in-class anti-FcγRIIA antibody (Ab) VIB9600 (previously known as MEDI9600) that blocks IgG immune complex-mediated cellular activation for cl...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ann Rheum Dis |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352406/ https://ncbi.nlm.nih.gov/pubmed/30459279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213523 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|